Home › Funds › Citigroup Inc › TRML
Citigroup Inc position in TRML
TOURMALINE BIO INC
Latest position (Q3 2025)1.42K sh
Reported value held$67.82K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 43.10K | $1.13M | New |
| Q1 2024 | 8.81K | $201.68K | Reduce |
| Q2 2024 | 5.73K | $73.64K | Reduce |
| Q3 2024 | 17.27K | $443.94K | Add |
| Q4 2024 | 31.01K | $628.94K | Add |
| Q1 2025 | 17.01K | $258.75K | Reduce |
| Q2 2025 | 9.79K | $156.61K | Reduce |
| Q3 2025 | 1.42K | $67.82K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.